Reckitt Benckiser Is Focus Of Acquisition Speculation In Personal Care
This article was originally published in The Rose Sheet
Executive Summary
As consumer products merger and acquisition activity revives, analysts are speculating about which players in the personal-care arena may be winding up for deals, with UK-based Reckitt Benckiser considered a likely suspect
You may also be interested in...
Reckitt Benckiser Looks Overseas To Double Adams’ Revenue
Reckitt Benckiser should meet its goal of doubling Adams Respiratory Therapeutics' revenues by launching the firms' OTC cough and congestion products overseas and introducing new products being developed by Adams in the United States, analysts and Reckitt executives say
Reckitt Spends $3.3 Bil. On Boots, Gains Clearasil Anti-Acne Brand
Reckitt Benckiser's $3.3 bil. (£1.9 bil.) cash purchase of Boots Healthcare International establishes the company as a significant player in the OTC consumer products market
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program